Immuneering Corp - Ordinary Shares Class A

NASDAQ:IMRX  
4.36
-0.09 (-2.02%)
Earnings Announcements

Immuneering Reports Second Quarter 2021 Financial Results And Provides Business Updates

Published: 09/09/2021 12:16 GMT
Immuneering Corp - Ordinary Shares Class A (IMRX) - Immuneering Reports Second Quarter 2021 Financial Results and Provides Business Updates.
Q2 Loss per Share $1.61.
Revenue is expected to be $0.17 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $0.16 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.